Top Markets
Coin of the day
CRISM Therapeutics Corporation CRISM Therapeutics Corporation

CRISM Therapeutics Corporation

CRTX
Rang in Aktien #40953
CRISM Therapeutics Corporation is dedicated to developing innovative drug... CRISM Therapeutics Corporation is dedicated to developing innovative drug delivery systems that enhance the effectiveness of cancer medications targeting solid tumors. Their primary offering, ChemoSeed, is designed for direct insertion into a tumor or the surgical site post-tumor removal, ensuring that therapeutic concentrations of chemotherapy agents are precisely localized to the cancerous tissue. This technology finds particular application in treating gliomas, a form of brain tumor. The company was established in 2016 and is headquartered in Road Town, British Virgin Islands.
Aktienkurs
$0.15137669
Marktkapitalisierung
$58.28K
Veränderung (1 Tag)
11.25%
Veränderung (1 Jahr)
6.17%
Land
VG
Handel CRISM Therapeutics Corporation (CRTX)

Kategorie

Kursverlauf für CRISM Therapeutics Corporation (CRTX)
Höchster Schlusskurs: $0.14 am 2026-08-01

Niedrigster Schlusskurs: $8.30K am 2003-10-01
Kursverlauf der Aktie von CRISM Therapeutics Corporation von 2003 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 16.09%
2025 -4.23%
2024 -23.28%
2023 -92.29%
2022 -34.29%
2021 2.89%
2020 -15.54%
2019 -30.02%
2018 -99.61%
2017 -27.55%
2016 7.69%
2015 -22.64%
2014 211.02%
2013 83.47%
2012 -82.11%
2011 51.68%
2010 -2.67%
2009 162,843.92%
2008 -99.98%
2007 5.00%
2006 -51.39%
2005 -9.54%
2004 36.47%
2003 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$524.11 32.38%
US
$869.90 34.53%
NL
$746.26 9.13%
CH
$1.08K -6.68%
KR
$260.48 16.92%
BE